Logo
Homepage
Explore Our Models
My Cart
Contact
Subscribe
Models
Genetically Engineered Animals
Knockout Mice
Knockout Rats
Knockin Mice
Knockin Rats
Transgenic Mice
Transgenic Rats
Model Generation Techniques
Turboknockout<sup>®</sup> Gene Targeting
ES Cell Gene Targeting
Targeted Gene Editing
Regular Transgenic
PiggyBac Transgenesis
BAC Transgenic
Research Models
HUGO-GT™ Humanized Mice
Cre Mouse Lines
Humanized Target Gene Models
Metabolic Disease Models
Ophthalmic Disease Models
Neurological Disease Models
Autoimmune Disease Models
Immunodeficient Mouse Models
Humanized Immune System Mouse Models
Oncology & Immuno-oncology Models
Covid-19 Mouse Models
MouseAtlas Model Library
Knockout Cell Line Product Catalog
Tumor Cell Line Product Catalog
AAV Standard Product Catalog
Animal Supporting Services
Breeding Services
Cryopreservation & Recovery
Phenotyping Services
BAC Modification
Custom Cell Line Models
Induced Pluripotent Stem Cells (iPSCs)
Knockout Cell Lines
Knockin Cell Lines
Point Mutation Cell Lines
Overexpression Cell Lines
Virus Packaging
Adeno-associated Virus (AAV) Packaging
Lentivirus Packaging
Adenovirus Packaging
CRO Services
By Therapeutic Area
Oncology
Ophthalmology
Neuroscience
Metabolic & Cardiovascular Diseases
Autoimmune & Inflammatory
By Drug Type
AI-Powered AAV Discovery
Gene Therapy
Oligonucleotide Therapy
Antibody Therapy
Cell Immunotherapy
Resources
Promotion
Events & Webinars
Newsroom
Blogs & Insights
Resource Vault
Reference Databases
Peer-Reviewed Citations
Rare Disease Data Center
AbSeek
Cell iGeneEditor™ System
OriCell
Quality
Facility Overview
Animal Health & Welfare
Health Reports
About Us
Corporate Overview
Our Partners
Careers
Contact Us
Login
Request a Product Quote
Select products from our catalogs and submit your request. Our team will get back to you with detailed information.
Full Name
Email
Phone Number
Organization
Job Role
Country
Catalog Type
Product Name
Additional Comments
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our Privacy Policy for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.
C57BL/6JCya-Tmem14aem1flox/Cya
Common Name:
Tmem14a-flox
Product ID:
S-CKO-16308
Background:
C57BL/6JCya
Product Type
Age
Genotype
Sex
Quantity
Price:
Contact for Pricing
Basic Information
Strain Name
Tmem14a-flox
Strain ID
CKOCMP-75712-Tmem14a-B6J-VA
Gene Name
Tmem14a
Product ID
S-CKO-16308
Gene Alias
5730496E24Rik; PTD011
Background
C57BL/6JCya
NCBI ID
75712
Modification
Conditional knockout
Chromosome
1
Phenotype
MGI:1922962
Document
Click here to download >>
Application
--
More
Rare Disease Data Center >>
Note
Note: When using this mouse strain in a publication, please cite “C57BL/6JCya-Tmem14aem1flox/Cya mice (Catalog S-CKO-16308) were purchased from Cyagen.”
Strain Description
Ensembl Number
ENSMUST00000027064
NCBI RefSeq
NM_001290679
Target Region
Exon 4
Size of Effective Region
~0.6 kb
Detailed Document
Click here to download >>
Overview of Gene Research
Tmem14a, a transmembrane protein, has been implicated in multiple biological processes. It contains a putative transmembrane domain and is an integral transmembrane protein of 99 amino acids with three transmembrane domains [3,4]. While its exact function is still being elucidated, studies suggest it may play roles in apoptosis regulation, cell proliferation, and energy metabolism, and is associated with maintaining the integrity of the glomerular filtration barrier [3,4].

In ovarian cancer, Tmem14a is highly expressed and is correlated with prognostic conditions. It inhibits cell apoptosis, accelerates energy metabolism like glycolysis and oxygen respiration, and is positively correlated with c-Myc. Overexpression of c-Myc can rescue its function, indicating its potential as a diagnostic and prognostic biomarker and a molecular target for therapy [1].

In non-small-cell lung cancer (NSCLC), AXL transcriptionally up-regulates Tmem14a expression to mediate cell proliferation. Silencing Tmem14a reduces cellular proliferation and ATP levels, suggesting it could be a therapeutic target for NSCLC patients undergoing AXL-targeted therapies [2].

In human ovarian cancer cells, knockdown of Tmem14a by RNAi reduces cell proliferation, causes cell cycle arrest, suppresses cell invasion, and down-regulates related proteins and the phosphorylation of Smad2 and Smad3 in the TGF-β signalling pathway, indicating a pro-tumorigenic effect [5].

In zebrafish embryos, knocking down tmem14a mRNA translation results in proteinuria, suggesting its role in maintaining glomerular filtration barrier integrity [4].

In conclusion, Tmem14a is involved in various biological processes, especially in cancer-related events such as cell apoptosis, proliferation, and invasion. Its role in maintaining the integrity of the glomerular filtration barrier is also significant. Functional studies, including those using gene knockdown models, have provided insights into its functions in specific disease conditions, highlighting its potential as a biomarker and therapeutic target in ovarian cancer and NSCLC [1,2,4,5].

References:
1. Zhang, Qingmei, Wang, Xiaohong, Zhang, Xuan, Jia, Jin, Chen, Jie. 2022. TMEM14A aggravates the progression of human ovarian cancer cells by enhancing the activity of glycolysis. In Experimental and therapeutic medicine, 24, 614. doi:10.3892/etm.2022.11551. https://pubmed.ncbi.nlm.nih.gov/36160886/
2. Jang, Te-Hsuan, Lin, Sheng-Chieh, Yang, Ya-Yu, Kuo, Tsu-Hsiang, Chuang, Shuang-En. 2023. AXL transcriptionally up-regulates TMEM14A expression to mediate cell proliferation in non-small-cell lung cancer cells. In Biochemical and biophysical research communications, 682, 365-370. doi:10.1016/j.bbrc.2023.10.027. https://pubmed.ncbi.nlm.nih.gov/37839105/
3. Woo, Im Sun, Jin, Hana, Kang, Eun Sil, Choi, Wan Sung, Seo, Han Geuk. 2011. TMEM14A inhibits N-(4-hydroxyphenyl)retinamide-induced apoptosis through the stabilization of mitochondrial membrane potential. In Cancer letters, 309, 190-8. doi:10.1016/j.canlet.2011.05.031. https://pubmed.ncbi.nlm.nih.gov/21723035/
4. Khalil, Ramzi, Bonnemaijer, Josephine D D, Kreutz, Reinhold, Hogendoorn, Pancras C W, Baelde, Hans J. . Transmembrane protein 14A protects glomerular filtration barrier integrity. In Physiological reports, 11, e15847. doi:10.14814/phy2.15847. https://pubmed.ncbi.nlm.nih.gov/38054547/
5. Zhang, Qingmei, Chen, Xiufeng, Zhang, Xuan, Zhan, Jingfen, Chen, Jie. 2016. Knockdown of TMEM14A expression by RNAi inhibits the proliferation and invasion of human ovarian cancer cells. In Bioscience reports, 36, e00298. doi:10.1042/BSR20150258. https://pubmed.ncbi.nlm.nih.gov/26896463/
Quality Control Standard
Sperm Test

Pre-cryopreservation: Measurement of sperm concentration, determination of sperm viability.

Post-cryopreservation: A vial of cryopreserved sperms is selected for in-vitro fertilization from each batch.

Environmental Standards:SPF
Available Region:Global
Source:Cyagen
Model Library
Model Library
Resources
Resources
Animal Quality
Animal Quality
Get Support
Get Support
Address:
2255 Martin Avenue, Suite E Santa Clara, CA 95050-2709, US
Tel:
800-921-8930 (8-6pm PST)
+1408-963-0306 (lnt’l)
Fax:
408-969-0338
Email:
animal-service@cyagen.com
service@cyagen.us
CRO Services
OncologyOphthalmologyNeuroscienceMetabolic & CardiovascularAutoimmune & InflammatoryGene TherapyAntibody Therapy
About Us
Corporate OverviewOur PartnersCareersContact Us
Social Media
Disclaimer: Pricing and availability of our products and services vary by region. Listed prices are applicable to the specific countries. Please contact us for more information.
Copyright © 2025 Cyagen. All rights reserved.
Privacy Policy
Site Map
Stay Updated with the Latest from Cyagen
Get the latest news on our research models, CRO services, scientific resources, and special offers—tailored to your research needs and delivered straight to your inbox.
Full Name
Email
Organization
Country
Areas of Interest